top of page
Preventing cervical cancer in
EVERY CLINIC, EVERYWHERE
Anchor 1
Ananya Health is freezing cervical cancer in its tracks
We are a medical device company building a platform to freeze abnormal cells in the cervix before they become malignant cervical cancer. Our cryoablation platform generates standard of care outcomes without consumable cryogen gas, and is specifically designed to overcome the barriers to cancer prevention.
Every 2 minutes, a woman dies of cervical cancer
Although cervical cancer is more than 90% preventable, and treatable before it becomes malignant, 40+ million people with a cervix lack access to early prevention technologies each year.
1-3
SCREENING
_edited.png)
A clinician can detect pre-cancerous cells through HPV DNA tests, Pap
smears, VIA, and other routine methods at a local clinic.
6-10% of cervical screens are abnormal, meaning some sort of follow-up
treatment or care is required.
4
.png)
_edited_edited.png)
GAPS IN CARE
50% of patients who screen positive never follow up, due to
at least one barrier.
5
.png)
.png)
Current standard of care treatment methods rely on a broken supply chain of costly, bulky gas canisters that are difficult to transport, or they require specialists like OB/GYNs who are
limited in number.
BARRIERS TO
TREATMENT
6-7
ONSET OF CANCER
When pre-cancer cells are left untreated, they progress into
cervical cancer — meaning that instead of
a simple intervention at a local clinic, a patient now faces surgery,
chemotherapy, or radiation.
AT ANANYA HEALTH,
Screen
Treat
TM
we are building tools to treat pre-cancerous cells at the point of diagnosis —
at any clinic, anywhere in the world.
MEET CRCL
TM
A portable, easy-to-use, and highly effective cryoablation platform
that can be used in any clinic, anywhere, to prevent
abnormal cervical lesions from progressing into cancer
Anchor 2
Closed loop system removes reliance on broken supply chain
Probe tip delivers 5mm depth of freeze–the standard of care–with controlled cooling
Battery-powered and portable design enables use in a wide range of settings
EXPANDING ACCESS
to more clinics and more women
Proven, standard-of-care outcomes = fewer cases of cervical cancer
More types of providers can provide effective treatment, overcoming the reliance on specialists
No consumable cryogen means more predictable costs for patients and providers
1/10th the cost per procedure of traditional
gas-based cryoablation
Our challenge is to ensure that...every woman over 30 is screened and treated for pre-cancerous lesions. To achieve that, we need innovative technologies and strategies.
Dr. Tedros Adhanom Ghebreyesus
WHO Director-General
Anchor 3
Team
_edited.jpg)
.png)
Advisors
_edited_edited_edited.jpg)
Anchor 4
News
October 2, 2023
Ananya Health’s cryoablation technology featured in Medical Design & Outsourcing’s Women in Medtech issue
The latest from our Instagram
TM
Ananya Health 2026
FCOI Policy | Certain configurations of the CRCL System shown on this website are under development and not currently available in any geography.
bottom of page